Genetically predicted levels of LRP12, prothrombin, angiopoietin-1 (ANGPT1), and low-density lipoprotein receptor–related protein 4 (LRP4) were positively associated with VTE and 3 cardiovascular diseases (Figure 5). This evidence concerns the gene LRP12 and cardiovascular disorder.